NDC 0003-7125 – Opdualag
Nivolumab 12 mg/mL; Relatlimab 4 mg/mL · Injection · Intravenous
Product NDC0003-7125
Product details
- Brand name
- Opdualag
- Generic name
- Nivolumab and relatlimab-rmbw
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- BLA · BLA761234
- Marketed since
- March 18, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Lymphocyte Activation Gene-3 Blocker; Programmed Death Receptor-1 Blocking Antibody
Active ingredients
- Nivolumab 12 mg/mL
- Relatlimab 4 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0003-7125-11 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0003-7125-11) / 20 mL in 1 VIAL, SINGLE-DOSE | Mar 18, 2022 |
Recalls mentioning this NDC
- D-0097-2026 Oct 29, 2025 · Class II
Lack of Assurance of Sterility.